Asthma: an anesthetic update. Part 3

M Karlet1, J Nagelhout

  • 1Duke University Nurse Anesthesia Program, Durham, NC, USA.

AANA Journal
|January 5, 2002
PubMed

Insights

Managing asthma patients during anesthesia remains challenging due to increasing global prevalence. Understanding asthma pathogenesis aids in developing personalized anesthetic plans and improving patient outcomes.

Area of Science:

  • Anesthesiology
  • Pulmonology
  • Pediatric Medicine

Background:

  • Asthma prevalence is rising globally, particularly in children, posing anesthetic challenges.
  • Evolving classification and treatment strategies for asthma require updated anesthetic approaches.
  • Bronchospastic episodes during anesthesia have decreased due to advancements in drugs and techniques.

Purpose of the Study:

  • To highlight the ongoing challenges in anesthetic management of asthma patients.
  • To emphasize the importance of understanding asthma pathogenesis for tailored anesthesia.
  • To review current best practices in anesthetic care for individuals with asthma.

Main Methods:

  • Review of current literature on asthma management and anesthesia.
  • Analysis of recent trends in anesthetic-induced bronchospasm.
  • Discussion of patient-specific anesthetic planning based on asthma pathophysiology.

Main Results:

  • Asthma management in anesthesia is complex but improving.
  • Decreased incidence of intraoperative bronchospasm observed.
  • Patient-specific anesthetic plans are crucial for optimal outcomes.

Conclusions:

  • Effective anesthetic management of asthma requires a deep understanding of its pathogenesis.
  • Personalized anesthetic strategies and current therapeutic advancements improve patient safety.
  • Continued research and adaptation of anesthetic techniques are vital for managing this growing patient population.

Related Concept Videos

Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...